PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New drug candidates show promise for cure for Chagas disease

2013-12-27
(Press-News.org) Contact information: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
New drug candidates show promise for cure for Chagas disease A team of researchers from Canada has developed a class of compounds which may help eradicate a neglected tropical disease that is currently hard to kill in its chronic form. The research was published ahead of print in Antimicrobial Agents and Chemotherapy.

Chagas disease or American trypanosomiasis, caused by Trypanosoma cruzi, affects about 18 million people living mostly in Latin America. The parasite is transmitted to humans by blood-sucking reduviid bugs, also known as kissing bugs due to their predilection for feeding on the faces of their victims. In the United States, Chagas disease is considered one of the neglected parasitic infections, a group of five parasitic diseases that have been targeted by CDC for public health action.

"While historically infection was largely confined to poor and rural populations in Central and South America, it has been emerging in the U.S., Canada, Europe, Japan, and Australia, due to immigration, and nonvectorial transmission is becoming a public health threat," says Deborah Nicoll-Griffith of the Merck Frosst Centre for Therapeutic Research in Kirkland, Quebec, a researcher on the study. One 2005 estimate put the number of people infected within the U.S. at 300,000 (1/1000).

There are two phases of Chagas disease: the acute phase and the chronic phase. Both phases can be symptom free or life threatening. Left untreated the disease can lead to cardiac and digestive disorders, as the parasite burrows into the heart, esophagus and colon tissue where it causes damage over time.

The current standard of care, the drug benznidazole, has significant activity against the parasite during the acute phase, but is less effective once the disease becomes chronic.

Efforts to find new drugs focus on disrupting an enzyme, cruzipain, which the parasite uses for digestion, to produce other cellular machinery, to evade the host's immune system, and to invade heart and gastrointestinal tissues.

Nicoll-Griffith and her colleagues identified two compounds known as reversible cysteine protease inhibitors that fit cruzipain like jigsaw puzzle pieces, jamming the enzyme. In the study, they tested the efficacy of the compounds in mice against that of benznidazole. While all treatment groups showed a marked reduction in parasite burden, in all tissues, the two experimental compounds had greater cure rates of acute infections (90% and 78%) compared to benznidazole (71%.)

"The efficacy shown in these T. cruzi murine studies suggests that nitrile-containing cruzipain inhibitors show promise as a viable approach for a safe and effective treatment of Chagas disease," write the researchers.

### A copy of the manuscript can be found online at http://bit.ly/asmtip1213e. The final version of the article is scheduled for the February 2014 issue of Antimicrobial Agents and Chemotherapy.

Antimicrobial Agents and Chemotherapy is a publication of the American Society for Microbiology (ASM). The ASM is the largest single life science society, composed of over 39,000 scientists and health professionals. Its mission is to advance the microbiological sciences as a vehicle for understanding life processes and to apply and communicate this knowledge for the improvement of health and environmental and economic well-being worldwide.


ELSE PRESS RELEASES FROM THIS DATE:

What does compassion sound like?

2013-12-27
What does compassion sound like? "Good to see you. I'm sorry. It sounds like you've had a tough, tough, week." Spoken by a doctor to a cancer patient, that statement is an example of compassionate behavior observed by a University of Rochester ...

Rock And Rho: Proteins that help cancer cells groove

2013-12-27
Rock And Rho: Proteins that help cancer cells groove Cells' adaptations to low oxygen conditions inside tumors promote breast cancer's spread Biologists at The Johns Hopkins University have discovered that low oxygen conditions, which often persist inside tumors, ...

UTSW study identifies potential therapeutic target for incurable, rare type of soft-tissue cancer

2013-12-27
UTSW study identifies potential therapeutic target for incurable, rare type of soft-tissue cancer DALLAS – Dec. 26, 2013 – A deadly, rare type of soft-tissue cancer may be completely eradicated simply by inhibiting a key protein involved ...

Toys, books, cribs harbor bacteria for long periods, study finds

2013-12-27
Toys, books, cribs harbor bacteria for long periods, study finds Streptococcus biofilms persisted on objects and surfaces in a daycare center, in some cases after a cleaning BUFFALO, N. Y. – Numerous scientific studies have concluded that two common bacteria that ...

Antioxidant drug knocks down multiple sclerosis-like disease in mice

2013-12-27
Antioxidant drug knocks down multiple sclerosis-like disease in mice PORTLAND, Ore. — Researchers at Oregon Health & Science University have discovered that an antioxidant designed more than a dozen years ago to fight damage within human cells significantly ...

Batteries as they are meant to be seen

2013-12-27
Batteries as they are meant to be seen In the search for long-lasting, inexpensive rechargeable batteries, researchers develop more realistic methods to study the materials in action Richland, Wash. -- Researchers have developed a way to microscopically ...

Discovering a 'THRIL' that correlates with severity of Kawasaki disease

2013-12-27
Discovering a 'THRIL' that correlates with severity of Kawasaki disease LA JOLLA, Calif., December 26, 2013 – Sanford-Burnham Medical Research Institute scientists have discovered a new molecule that forms when certain white blood cells—macrophages—are stimulated ...

Who is using MyPlate?

2013-12-27
Who is using MyPlate? Food preferences, cooking ability, involvement of children in food preparation, nutritional knowledge, and prior familiarity with MyPyramid were predictors of MyPlate awareness and use Most Americans know about MyPyramid – the triangle ...

BU researchers explore possible link between cognitive depressive symptoms and antiretroviral therapy uptake

2013-12-21
BU researchers explore possible link between cognitive depressive symptoms and antiretroviral therapy uptake Researchers from Boston University's School of Medicine (BUSM) and College of Arts and Sciences (CAS) found that among HIV-infected Russian drinkers, ...

Wayne State University physicists publish observation of the 'Charming Socialites'

2013-12-21
Wayne State University physicists publish observation of the 'Charming Socialites' DETROIT — Protons and neutrons, the particles in an atomic nucleus, are made of smaller pieces called "quarks." Some types of quarks ...

LAST 30 PRESS RELEASES:

Next-generation AI and big data: Transforming crop breeding

Biomimetic synthesis of natural products: Progress, challenges and prospects

New limits found for dark matter properties from latest search

SCAI expresses disappointment over ABMS decision to deny independent cardiovascular medicine boar

Rice researchers develop efficient lithium extraction method, setting stage for sustainable EV battery supply chains

Statement on ABMS denying new cardiovascular board

St. Jude scientists solve mystery of how the drug retinoic acid works to treat neuroblastoma

New device could allow you to taste a cake in virtual reality

Illinois researchers develop next-generation organic nanozymes and point-of-use system for food and agricultural uses

Kicking yourself: Going against one’s better judgment amplifies self-blame

Rice researchers harness gravity to create low-cost device for rapid cell analysis

Revolutionary copper-infused microvesicles: a new era in biofunctional medicine

Primary care practices with NPs are key to increasing health care access in less advantaged areas, Columbia Nursing study shows

TTUHSC conducting study to help patients that experience traumatic blood loss

Next top model: Competition-based AI study aims to lower data center costs

Innovative startup awarded $10,000 to tackle cardiovascular disparities

Study compares indoor transmission-risk metrics for infectious diseases

Micro-expression detection in ASD movies: a YOLOv8-SMART approach

Machine learning on blockchain: A new approach to engineering computational security

Vacuum glazing: A promising solution for low-carbon buildings

Racial and ethnic differences in out-of-pocket spending for maternity care

Study reveals racial and ethnic disparities in maternity care spending

Changes in food insecurity among US adults with low income during the COVID-19 pandemic

After NIH decision to cap indirect costs, prominent molecular biologist calls for swift action, petition signatures

Omitting race from lung function equations increases detection of asthma in Black children

The role of solute carrier family transporters in hepatic steatosis and hepatic fibrosis

Cold sore discovery IDs unknown trigger for those annoying flare-ups

Health organizations join forces on Rare Disease Day for idiopathic pulmonary fibrosis

How many languages can you learn at the same time? – Ghanaian babies grow up speaking two to six languages

Virginia Tech to lead $10 million critical mineral research coalition in Appalachia

[Press-News.org] New drug candidates show promise for cure for Chagas disease